Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 755 All time
- Disclosed funding
- $25.4B 617 disclosed amounts
- Median round
- $15.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| O OrebellaCompany profile Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail | Undisclosed | Series A | Healthtech, Consumer | United States | Investors | |
| GH Garner HealthCompany profile Helps patients choose healthcare providers using data and financial incentives. Helps patients choose healthcare providers using data and financial incentives. | $100M | Series ESeries C+ | Healthtech | United States | Investors | |
| KH Kubera HealthCompany profile Building the contract-to-payment system of record for American healthcare Building the contract-to-payment system of record for American healthcare | $6.5M | Seed | Healthtech | United States | Investors | |
| H H1Company profile Sells detailed information about doctors to pharma companies, hospital systems, and health insurers Sells detailed information about doctors to pharma companies, hospital systems, and health insurers | $40M | StrategicUndisclosed | Healthtech | United States | Investors | |
| CL Develops single-molecule PCR technology for genomics measurement | $26M | Series A | Healthtech, Biotech | United States | Investors | |
| T TriomicsCompany profile Building AI infrastructure to turn complex cancer records into structured intelligence Building AI infrastructure to turn complex cancer records into structured intelligence | $22M | Series B | Healthtech | United States | Investors | |
| S AI-native marketing agency accelerating pharma commercialization | $21M | Series A | Healthtech | United States | Investors | |
| P PsileraCompany profile Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions | $8.8M | Seed+Seed | Healthtech, Biotech | United States | Investors Undisclosed | |
| EL Ember LifeSciencesCompany profile Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution | $27M | Series A | Healthtech | United States | Investors | |
| ST Secretome TherapeuticsCompany profile Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy | $30M | Series A | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.